http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103012291-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d94573ab2c57e8b193f3a22accddf9fe
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
filingDate 2012-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c3b9ee4bbb1818e2a084bcf9955261c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64ef899c3167c2f1002d044acf526179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ae82feebc1c4dcb6dfa32869db11a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53a618601a5640a8883e80d5e0d1ecb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f10909d4bf2c179461451e9446be3d89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5007a1007b037e6f801e1dbb7f410fd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd83eb074fd8962d2f1604b7f0aaa842
publicationDate 2013-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103012291-A
titleOfInvention A kind of 2-phenylquinazoline derivatives and its preparation method and application in the preparation of anticancer drugs
abstract The invention relates to the field of medicinal chemistry, in particular to a 2-phenylquinazoline derivative. The structural formula of this 2-phenylquinazoline derivative is: In the formula, R 1 is NH(CH 2 ) 3 N(CH 3 ) 2 ; R2 is Cl or H; R 3 is NHCO(CH 2 ) n NR 4 or NHCO(CH 2 ) n NH(CH 2 ) n NR4, n=1, 2, 3, 4 or 5, NR 4 represents two C 1-6 alkyl groups or two C 3-6 cycloalkyl groups connected to the N atom, or NR 4 represents morpholinyl, piperazine base or pyrrolidinyl. The invention also discloses a preparation method of the 2-phenylquinazoline derivative. The 2-phenylquinazoline derivatives involved in the present invention have a strong inhibitory effect on the expression of telomeric DNA, have significant inhibitory effects on various cancer cell lines, and have little toxicity to normal cells, and are useful in the preparation of anticancer drugs. has a broad application space.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107540662-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107540662-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103755649-A
priorityDate 2012-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101967127-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3740402-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0228841-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465663557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72197259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465307263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163666769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72196518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465445919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466577146

Total number of triples: 33.